A detailed history of Dn B Asset Management As transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Dn B Asset Management As holds 8,383 shares of CRL stock, worth $1.67 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
8,383
Previous 7,187 16.64%
Holding current value
$1.67 Million
Previous $1.95 Million 11.09%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 05, 2024

BUY
$206.39 - $268.73 $246,842 - $321,401
1,196 Added 16.64%
8,383 $1.73 Million
Q1 2024

Apr 12, 2024

BUY
$203.52 - $273.43 $1.46 Million - $1.97 Million
7,187 New
7,187 $1.95 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $10.1B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Dn B Asset Management As Portfolio

Follow Dn B Asset Management As and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dn B Asset Management As, based on Form 13F filings with the SEC.

News

Stay updated on Dn B Asset Management As with notifications on news.